Boan Li

1.6k total citations
50 papers, 941 citations indexed

About

Boan Li is a scholar working on Epidemiology, Hepatology and Cancer Research. According to data from OpenAlex, Boan Li has authored 50 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 17 papers in Hepatology and 13 papers in Cancer Research. Recurrent topics in Boan Li's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis B Virus Studies (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Boan Li is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatitis B Virus Studies (11 papers) and Hepatocellular Carcinoma Treatment and Prognosis (8 papers). Boan Li collaborates with scholars based in China, United States and Philippines. Boan Li's co-authors include Qiyu Jiang, Fan Feng, Yingshi Zhang, Shuang Cao, Qingchun Zhao, Huiwei Sun, Yantao Chai, Xiaojuan Li, Jun Hou and Na Lin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Microbiology and Emerging infectious diseases.

In The Last Decade

Boan Li

48 papers receiving 920 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boan Li China 18 414 276 174 172 160 50 941
Jiping Wang China 15 871 2.1× 826 3.0× 97 0.6× 100 0.6× 145 0.9× 25 1.3k
Bruna Scaggiante Italy 24 873 2.1× 359 1.3× 45 0.3× 238 1.4× 74 0.5× 66 1.3k
Cristina Sanz Spain 22 530 1.3× 89 0.3× 34 0.2× 313 1.8× 117 0.7× 71 2.0k
Hui Qiu China 17 224 0.5× 122 0.4× 45 0.3× 295 1.7× 93 0.6× 74 845
Oliver Glass United States 14 256 0.6× 131 0.5× 62 0.4× 183 1.1× 165 1.0× 21 714
Christine L. Zimmer Germany 17 898 2.2× 38 0.1× 191 1.1× 366 2.1× 267 1.7× 31 1.7k
Rachel Purcell New Zealand 17 806 1.9× 202 0.7× 28 0.2× 525 3.1× 119 0.7× 46 1.3k
Rasoul Baharlou Iran 15 278 0.7× 112 0.4× 66 0.4× 210 1.2× 71 0.4× 55 783
Alexandra Roth United States 14 311 0.8× 140 0.5× 17 0.1× 177 1.0× 68 0.4× 18 839
Akiko Iwata Japan 22 428 1.0× 37 0.1× 73 0.4× 65 0.4× 143 0.9× 66 1.2k

Countries citing papers authored by Boan Li

Since Specialization
Citations

This map shows the geographic impact of Boan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boan Li more than expected).

Fields of papers citing papers by Boan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boan Li. The network helps show where Boan Li may publish in the future.

Co-authorship network of co-authors of Boan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Boan Li. A scholar is included among the top collaborators of Boan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boan Li. Boan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Shixin, Nanshan Zheng, Jing Zhao, et al.. (2025). Development of PDAC diagnosis and prognosis evaluation models based on machine learning. BMC Cancer. 25(1). 512–512. 2 indexed citations
2.
Li, Boan, Kun Hao, Ailan Wang, et al.. (2024). Five miRNAs identified in fucosylated extracellular vesicles as non-invasive diagnostic signatures for hepatocellular carcinoma. Cell Reports Medicine. 5(9). 101716–101716. 17 indexed citations
3.
Chen, Suming, Ting Yu, Fangzhou Chen, et al.. (2024). Replicon-Based Typing About IncG Plasmids and Molecular Characterization of Five IncG Plasmids Carrying Carbapenem Resistance Gene blaKPC-2. Infection and Drug Resistance. Volume 17. 2987–2999.
4.
Wang, Hongbo, Xiaofeng Zhang, Peng Zhang, et al.. (2023). TPX2 enhances the transcription factor activation of PXR and enhances the resistance of hepatocellular carcinoma cells to antitumor drugs. Cell Death and Disease. 14(1). 64–64. 19 indexed citations
5.
Xu, Meihong, Qiyu Jiang, Huiwei Sun, et al.. (2022). A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma. Frontiers in Pharmacology. 13. 951831–951831. 6 indexed citations
6.
Li, Bo, Yi Wen, Guang Yang, et al.. (2021). The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real‐world data. Journal of Clinical Laboratory Analysis. 35(9). e23932–e23932. 10 indexed citations
7.
He, Xi, Huiwei Sun, Qiyu Jiang, et al.. (2021). Hsa-miR-4277 Decelerates the Metabolism or Clearance of Sorafenib in HCC Cells and Enhances the Sensitivity of HCC Cells to Sorafenib by Targeting cyp3a4. Frontiers in Oncology. 11. 735447–735447. 19 indexed citations
8.
9.
Li, Boan, Fan Feng, Yong-Shou Chen, et al.. (2020). <p>Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents</p>. OncoTargets and Therapy. Volume 13. 7165–7176. 34 indexed citations
10.
Chang, De, Peng Zhao, Dawei Zhang, et al.. (2020). Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19. The Journal of Allergy and Clinical Immunology In Practice. 8(8). 2585–2591.e1. 33 indexed citations
11.
Zeng, Yongbin, Jinpiao Lin, Tianbin Chen, et al.. (2020). IL-17 and IL-21 polymorphisms in relation to HBV related hepatocellular carcinoma in Chinese Han population. Infection Genetics and Evolution. 87. 104638–104638. 6 indexed citations
12.
Wang, Yijin, Huiying Rao, Xiumei Chi, et al.. (2019). Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality. EBioMedicine. 46. 227–235. 28 indexed citations
13.
Chen, Lin, Licheng Liu, Xiaoguang Zhang, et al.. (2018). A rapid point-of-care test for dengue virus-1 based on a lateral flow assay with a near-infrared fluorescent dye. Journal of Immunological Methods. 456. 23–27. 18 indexed citations
14.
Li, Yan, et al.. (2018). Combination of PCT, sNFI and dCHC for the diagnosis of ascites infection in cirrhotic patients. BMC Infectious Diseases. 18(1). 389–389. 7 indexed citations
15.
Li, Jiaqi, Jing Zhao, Huan Wang, et al.. (2018). MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor. OncoTargets and Therapy. Volume 11. 5885–5894. 46 indexed citations
16.
Zhang, Yingshi, Qiyu Jiang, Shuang Cao, et al.. (2018). Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. Cell Death and Disease. 9(7). 743–743. 93 indexed citations
17.
Feng, Fan, Yingshi Zhang, Jun Hou, et al.. (2017). Can music improve sleep quality in adults with primary insomnia? A systematic review and network meta-analysis. International Journal of Nursing Studies. 77. 189–196. 82 indexed citations
18.
Shen, Honghui, Jun Hou, Weiwei Chen, et al.. (2011). Immunologic Changes during Pandemic (H1N1) 2009, China. Emerging infectious diseases. 17(6). 1053–1055. 12 indexed citations
19.
Liu, Jia, et al.. (2010). [Evaluation on clinical value of serum CA-125 level in hepatitis cirrhosis].. PubMed. 24(5). 334–6. 3 indexed citations
20.
Li, Jin, et al.. (2000). Serological and histological findings in infection and transmission of GBV-C/HGV to macaques. Journal of Medical Virology. 60(1). 28–33. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiping Wang Breakdown of academic impact, for papers by Bruna Scaggiante Breakdown of academic impact, for papers by Cristina Sanz Breakdown of academic impact, for papers by Hui Qiu Breakdown of academic impact, for papers by Oliver Glass Breakdown of academic impact, for papers by Christine L. Zimmer Breakdown of academic impact, for papers by Rachel Purcell Breakdown of academic impact, for papers by Rasoul Baharlou Breakdown of academic impact, for papers by Alexandra Roth Breakdown of academic impact, for papers by Akiko Iwata
Rankless by CCL
2026